Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. A significant proportion of patients with NAFLD develop a progressive inflammatory condition termed nonalcoholic steatohepatitis (NASH), which may eventually advance to cirrhosis and hepatocellular carcinoma (HCC). NASH is characterized by steatosis, hepatocyte ballooning, and lobular inflammation. Heightened immune cell infiltration is a hallmark of NASH, yet the mechanisms whereby hepatic inflammation occurs in NASH and how it contributes to disease initiation and progression remain incompletely understood. Emerging evidence indicates that intrahepatic T cell immune mechanisms play an integral role in the pathogenesis of NASH and its transition to HCC. In this review, we summarize the current knowledge regarding the T cell-mediated mechanisms of inflammation in NASH. We highlight recent preclinical and human studies implicating various subsets of conventional and innate-like T cells in the onset and progression of NASH and HCC. Finally, we discuss the potential therapeutic strategies targeting T cell-mediated responses for the treatment of NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339 · cited 1×
“In homeostatic conditions, the liver contains a population of tissue-resident macrophages known as Kupffer cells (KCs) that originate from yolk sac progenitors and are scarcely replaced by monocytes from hematopoietic origin (12).”
BackgroundMechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · cited 1×
“An estimated 20% of patients with NASH progress to cirrhosis over two to four decades (2, 4).”
BackgroundPreferential Localization of Effector Memory Cells in Nonlymphoid Tissue
Masopust, D., Vezys, V., Marzo, A. L., & Lefrançois, L. (2001) · Science · doi:10.1126/science.1058867 · Cited by 1,952
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858 · cited 1×
“NAFLD affects approximately 25% of the world population and represents the most common chronic liver impairment, contributing to the burden of end-stage liver disease worldwide (3).”
BackgroundGlobal epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552 · cited 2×
“In healthy human livers, the majority of CD8 T cells are conventional ab TCR+ T cells with enriched expression of CD69 and a tissueresident memory phenotype (42).”
BackgroundPlasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414 · cited 1×
“Although Th17 cells show protective functions against bacteria and fungi infections, excessive release of Th17 cytokines has been implicated in chronic inflammation (58).”
BackgroundNASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
Human T cell development, localization, and function throughout life
Kumar, B. V., Connors, T. J., & Farber, D. L. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.007 · Cited by 1,257
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943 · cited 1×
“Although identifying the factors that trigger inflammation in the transition from NAFL to NASH is a primary goal of the field (123), limited research has been conducted to determine the intrinsic and extrinsic mechanisms of T cell activation.”
BackgroundThe role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941 · cited 1×
“Innate immune cells, particularly macrophages, have emerged as essential players in the progression of NASH and have been the focus of intensive research (11).”
BackgroundNAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766 · cited 2×
“Despite the evidence showing that the accumulation of Th1 and Th17 cells promotes NASH, other studies suggest that dysregulation of lipid metabolism during NAFL and NASH causes a selective loss of CD4 T cells that leads to impaired anti-tumor surveillance in mouse models and human samples (68, 69).”
BackgroundWolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678 · cited 6×
“Similarly, b2 microglubulin knockout (b2m-/-) mice that have a severe deficiency of CD8 T cells are protected from CD-HFD-induced liver damage and tumorigenesis, suggesting that CD8 T cells promote HCC (46).”
BackgroundInfluentialHepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661 · cited 1×
“During inflammation or immune responses to pathogens, hepatic CD8 TRM cells can acquire an effector memory phenotype (CCR7- CD44+ CD62L-) that secretes interferon (IFN)g or a central memory phenotype (CD44+ CCR7+ CD62L+) that is important for long-term immunity (43).”
BackgroundBonnardel, J., T’Jonck, W., Gaublomme, D., Browaeys, R., Scott, C. L., Martens, L., Vanneste, B., De Prijck, S., Nedospasov, S. A., Kremer, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.017 · Cited by 631 · cited 1×
“the liver, the maintenance of KCs is shaped by the production of macrophage growth factors by neighboring cells, most notably hepatic stellate cells (HSCs) (13).”
BackgroundBaeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
In Vivo CD4 + T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm
Ruterbusch, M., Pruner, K. B., Shehata, L., & Pepper, M. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-103019-085803 · Cited by 550
γδ T cells in tissue physiology and surveillance
Ribot, J. C., Lopes, N., & Silva-Santos, B. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00452-4 · Cited by 532
Past, present and future perspectives in nonalcoholic fatty liver disease
Sanyal, A. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0144-8 · Cited by 522 · cited 3×
“Notably, the presence of liver fibrosis is the main predictor of morbidity and mortality in patients with NASH (2).”
BackgroundAuto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03233-8 · Cited by 518 · cited 5×
“Given that excessive hepatocyte apoptosis promotes HCC in NASH and CXCR6+ CD8 T cells cause non-specific hepatocyte killing (45, 115), CD8 T cells likely fueled the liver carcinogenesis in the CDHFD model.”
BackgroundInfluentialSaravia, J., Chapman, N. M., & Chi, H. (2019) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0220-6 · Cited by 489 · cited 18×
“Tregs express FOXP3 and CD25 (IL-2 receptor alpha) and can be classified into natural Tregs, that derive from the thymus via TCR-mediated recognition of self-antigens, and Tregs induced in the periphery in the presence of IL-2 and TGF-b (59).”
BackgroundInfluentialGomes, A. L., Teijeiro, A., Burén, S., Tummala, K. S., Yilmaz, M., Waisman, A., Theurillat, J.-P., Perna, C., & Djouder, N. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.020 · Cited by 401 · cited 4×
“Th17 cells produce IL-17A, IL-17F, and IL-21, and their development is governed by IL-6, TGF-b, IL-1b, and IL-23 (57).”
BackgroundInfluentialTran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gélineau, A., Marcelin, G., Magréau-Davy, E., Ouhachi, M., Lesnik, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.003 · Cited by 400 · cited 5×
“KCs can also release chemokines that promote the infiltration of proinflammatory monocyte-derived macrophages (MoMFs) (16).”
BackgroundInfluentialWang, H., Zhang, H., Wang, Y., Brown, Z. J., Xia, Y., Huang, Z., Shen, C., Hu, Z., Beane, J., Ansa-Addo, E. A., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.032 · Cited by 398 · cited 1×
“However, a recent report showed that Tregs increase in the liver during NASH, and that their depletion inhibits the progression from NASH to HCC in a mouse model of choline-deficient, high-fat diet feeding and diethylnitrosamine injection (74).”
BackgroundSelf-citationIL-17 regulates adipogenesis, glucose homeostasis, and obesity
Zúñiga, L. A., Shen, W.-J., Joyce-Shaikh, B., Pyatnova, E. A., Richards, A. G., Thom, C., Andrade, S. M., Cua, D. J., Kraemer, F. B., & Butcher, E. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001269 · Cited by 394
Daemen, S., Gainullina, A., Kalugotla, G., He, L., Chan, M. M., Beals, J. W., Liss, K. H., Klein, S., Feldstein, A. E., Finck, B. N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108626 · Cited by 378 · cited 5×
“KCs can also release chemokines that promote the infiltration of proinflammatory monocyte-derived macrophages (MoMFs) (16).”
BackgroundInfluentialAdaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374 · cited 2×
“Profiling of peripheral and intrahepatic leukocytes has revealed an increase in the accumulation of inflammatory Th1 and Th17 cells during NASH in humans and mouse models of disease (27, 63, 64).”
BackgroundObesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Grohmann, M., Wiede, F., Dodd, G. T., Gurzov, E. N., Ooi, G. J., Butt, T., Rasmiena, A. A., Kaur, S., Gulati, T., Goh, P. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.053 · Cited by 373 · cited 2×
“Mechanistically, it has been shown that inactivation of T cell protein tyrosine phosphatase (TCPTP) in hepatocytes can drive STAT-1 and STAT-3-dependent gene expression of T cell chemoattractants such as CXCL9 that promote T cell recruitment (113).”
BackgroundImajo, K., Fujita, K., Yoneda, M., Nozaki, Y., Ogawa, Y., Shinohara, Y., Kato, S., Mawatari, H., Shibata, W., Kitani, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.012 · Cited by 341 · cited 1×
“During the initiation of NASH, KCs sense disturbances in the tissue, such as increased lipopolysaccharide and fatty acids, and initiate hepatic inflammation and fibrosis through the production of tumor necrosing factor (TNF)a (14) and interleukin (IL)-1b (15).”
BackgroundMyD88 Signaling in T Cells Directs IgA-Mediated Control of the Microbiota to Promote Health
Kubinak, J. L., Petersen, C., Stephens, W. Z., Soto, R., Bake, E., O’Connell, R. M., & Round, J. L. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.12.009 · Cited by 328
Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501175 · Cited by 302 · cited 7×
“In agreement, a higher frequency of CD4 T cells expressing IFNg and IL-4 has been reported in the peripheral blood of patients with NASH compared with healthy individuals (63).”
BackgroundResultInfluentialInterleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Tang, Y., Bian, Z., Zhao, L., Liu, Y., Liang, S., Wang, Q., Han, X., Peng, Y., Chen, X., Shen, L., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04471.x · Cited by 294
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
Syn, W.-K., Oo, Y. H., Pereira, T. A., Karaca, G. F., Jung, Y., Omenetti, A., Witek, R. P., Choi, S. S., Guy, C. D., Fearing, C. M., et al. (2010) · Hepatology · doi:10.1002/hep.23599 · Cited by 283
Therapeutic pipeline in nonalcoholic steatohepatitis
Vuppalanchi, R., Noureddin, M., Alkhouri, N., & Sanyal, A. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00408-y · Cited by 278 · cited 1×
“org 2 therapies for the treatment of NASH, although several drugs and their combinations are at various stages of clinical development with suboptimal preliminary results (7).”
BackgroundHou, J., Zhang, J., Cui, P., Zhou, Y., Liu, C., Wu, X., Ji, Y., Wang, S., Cheng, B., Ye, H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135197 · Cited by 239 · cited 1×
“Although, the accumulation of macrophages during NASH is associated with the progression of the disease, a remarkable subset of macrophages expressing the lipid receptor Trem2 has been shown to promote tissue homeostasis by coordinating hepatocyte energy supply and mitochondrial function (19).”
BackgroundThe Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
Van Herck, M. A., Weyler, J., Kwanten, W. J., Dirinck, E. L., De Winter, B. Y., Francque, S. M., & Vonghia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00082 · Cited by 238 · cited 1×
“Hepatic innate-like T lymphocytes, such as natural killer T (NKT) cells, gd T cells, and mucosal-associated invariant T cells (MAITs), have been implicated in the pathogenesis of NASH in humans and mice (76).”
BackgroundMucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04450-y · Cited by 232
Koda, Y., Teratani, T., Chu, P.-S., Hagihara, Y., Mikami, Y., Harada, Y., Tsujikawa, H., Miyamoto, K., Suzuki, T., Taniki, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24734-0 · Cited by 219
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
Ibrahim, S. H., Hirsova, P., Malhi, H., & Gores, G. J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3977-1 · Cited by 218
Self-citationBarrow, F., Khan, S., Fredrickson, G., Wang, H., Dietsche, K., Parthiban, P., Robert, S., Kaiser, T., Winer, S., Herman, A., et al. (2021) · Hepatology · doi:10.1002/hep.31755 · Cited by 210 · cited 1×
“Depletion of B2 cells in mice fed a western (30) or a methionineand choline-deficient (MCD) (29) diet prevents hepatic inflammation and reduces T helper (Th)1 responses, suggesting a causative role for B cells in NASH progression.”
BackgroundSelf-citationThe Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
Cai, J., Zhang, X., & Li, H. (2019) · Hepatology · doi:10.1002/hep.30506 · Cited by 207 · cited 1×
“In contrast, NASH is characterized by a substantial accumulation of innate and adaptive immune cells that become activated and promote inflammation (10) (Figure 2).”
BackgroundGut‐liver axis at the frontier of host‐microbial interactions
Brandl, K., Kumar, V., & Eckmann, L. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00361.2016 · Cited by 201
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Deczkowska, A., David, E., Ramadori, P., Pfister, D., Safran, M., Li, B., Giladi, A., Jaitin, D. A., Barboy, O., Cohen, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01344-3 · Cited by 197
Li, F., Hao, X., Chen, Y., Bai, L., Gao, X., Lian, Z., Wei, H., Sun, R., & Tian, Z. (2017) · Nature Communications · doi:10.1038/ncomms13839 · Cited by 191 · cited 5×
“In mice, the microbiota appears to control the number of hepatic-resident gd T cells and their homeostasis in a lipid antigen-CD1d-dependent manner (98).”
BackgroundResultInfluentialType I Interferon Responses Drive Intrahepatic T Cells to Promote Metabolic Syndrome
Ghazarian, M., Revelo, X. S., Nøhr, M. K., Luck, H., Zeng, K., Lei, H., Tsai, S., Schroer, S. A., Park, Y. J., Chng, M. H. Y., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai7616 · Cited by 190 · cited 11×
“Role of Hepatic gd T Cells in NASH The number of intrahepatic gd T cells and IL-17-producing gd T cells are substantially increased after high-fat diet feeding in mice (52, 98).”
BackgroundInfluentialSelf-citationDendritic Cells Limit Fibroinflammatory Injury in Nonalcoholic Steatohepatitis in Mice
Henning, J. R., Graffeo, C. S., Rehman, A., Fallon, N. C., Zambirinis, C. P., Ochi, A., Barilla, R., Jamal, M., Deutsch, M., Greco, S., et al. (2013) · Hepatology · doi:10.1002/hep.26267 · Cited by 185 · cited 1×
“For instance, studies using mouse models of NASH have proposed a role for cDCs in preventing fibrosis and inflammation (22, 23).”
BackgroundBöttcher, K., Rombouts, K., Saffioti, F., Roccarina, D., Rosselli, M., Hall, A., Luong, T., Tsochatzis, E. A., Thorburn, D., & Pinzani, M. (2018) · Hepatology · doi:10.1002/hep.29782 · Cited by 183 · cited 1×
“Notably, MAIT cells have been shown to promote proinflammatory responses and HSC activation with consequent liver fibrogenesis in chronic and autoimmune liver disease (104, 105).”
BackgroundHaas, J. T., Vonghia, L., Mogilenko, D. A., Verrijken, A., Molendi-Coste, O., Fleury, S., Deprince, A., Nikitin, A., Woitrain, E., Ducrocq-Geoffroy, L., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0076-1 · Cited by 155 · cited 1×
“cells in the liver correlates with elevated frequency of blood CD8 T cells expressing perforin, IFNg, and TNFa, raising the possibility of systemic activation or crosstalk with other tissues (50).”
BackgroundHepatic natural killer T‐cell and CD8+ T‐cell signatures in mice with nonalcoholic steatohepatitis
Bhattacharjee, J., Kirby, M., Softic, S., Miles, L., Salazar‐Gonzalez, R., Shivakumar, P., & Kohli, R. (2017) · Hepatology Communications · doi:10.1002/hep4.1041 · Cited by 146
Bruzzì, S., Sutti, S., Giudici, G., Burlone, M. E., Ramavath, N. N., Toscani, A., Bozzola, C., Schneider, P., Morello, E., Parola, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.015 · Cited by 139
Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release
Pan, J., Ou, Z., Cai, C., Li, P., Gong, J., Ruan, X. Z., & He, K. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.08.006 · Cited by 132
The Emerging Role of B Cells in the Pathogenesis of NAFLD
Barrow, F., Khan, S., Wang, H., & Revelo, X. S. (2021) · Hepatology · doi:10.1002/hep.31889 · Cited by 126 · cited 2×
“Mechanistically, NASH livers seem to accumulate B cells with elevated proinflammatory cytokine secretion and antigenpresentation ability following activation through the innate adaptor myeloid differentiation primary response protein 88 (28).”
BackgroundSelf-citationLuo, X.-Y., Takahara, T., Kawai, K., Fujino, M., Sugiyama, T., Tsuneyama, K., Tsukada, K., Nakae, S., Zhong, L., & Li, X.-K. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00193.2013 · Cited by 120 · cited 1×
“Supporting a potential role for CD4 T cells in promoting NASH through the release of proinflammatory cytokines, whole-body IFNg deficiency attenuates disease progression in mice fed an MCDhigh-fat diet including a reduced activation and infiltration of intrahepatic macrophages (65).”
BackgroundRensen, S. S., Bieghs, V., Xanthoulea, S., Arfianti, E., Bakker, J. A., Shiri-Sverdlov, R., Hofker, M. H., Greve, J. W., & Buurman, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052411 · Cited by 116
Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149783 · Cited by 116
Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis
Heier, E.-C., Meier, A., Julich-Haertel, H., Djudjaj, S., Rau, M., Tschernig, T., Geier, A., Boor, P., Lammert, F., & Lukacs-Kornek, V. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.008 · Cited by 94 · cited 1×
“For instance, studies using mouse models of NASH have proposed a role for cDCs in preventing fibrosis and inflammation (22, 23).”
BackgroundMaricic, I., Marrero, I., Eguchi, A., Nakamura, R., Johnson, C. D., Dasgupta, S., Hernandez, C. D., Nguyen, P. S., Swafford, A. D., Knight, R., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800614 · Cited by 92 · cited 1×
“Similarly, in db/db mice or animals fed a choline-deficient Lamino acid–defined diet, iNKT cell deficiency ameliorates tissue inflammation, hepatic steatosis, and fibrosis (87, 93).”
BackgroundRai, R. P., Liu, Y., Iyer, S. S., Liu, S., Gupta, B., Desai, C., Kumar, P., Smith, T., Singhi, A. D., Nusrat, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.047 · Cited by 86 · cited 3×
“Several potential approaches have been tested in preclinical settings, including the inhibition of pathogenic CD4 T cell recruitment using a neutralizing monoclonal antibody against a4b7 that was successful at preventing binding of a4b7-bearing CD4 T cells toMAdCAM-1 in the liver and intestine and resulted in attenuat…”
BackgroundInfluentialγδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Torres‐Hernandez, A., Wang, W., Nikiforov, Y., Tejada, K., Torres, L., Kalabin, A., Adam, S., Wu, J., Lu, L., Chen, R., et al. (2020) · Hepatology · doi:10.1002/hep.30952 · Cited by 80 · cited 1×
“Similarly, Tcrd-/- mice fed an MCD diet displayed attenuated liver steatosis, injury, and hepatic leukocyte infiltration, including a decreased influx of inflammatory monocytes (100).”
Background
Cited by
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
Sawada, K., Chung, H., Softic, S., Moreno-Fernandez, M. E., & Divanovic, S. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.009 · Cited by 139
Hepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79
“T cells may be especially important in promoting NASH and NASH-HCC (116, 130).”
BackgroundMechanisms of liver fibrosis in metabolic syndrome
Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28
“53”
Metadata
- Authors
- Hirsova, P., Bamidele, A. O., Wang, H., Povero, D., & Revelo, X. S.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2021-10-28
- Volume
- 12
- Pages
- 760860-760860
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W3210485981
- Cited by
- 70
- References
- 61
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.